Why is "Fluvoxamine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-26 03:02:56
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and, perhaps more-especially, obsessive–compulsive disorder (OCD), but is also used to treat anxiety disorders such as panic disorder, social anxiety disorder, and post-traumatic stress disorder.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Fluvoxamine improves fatigue and quality of life in long COVID - 2 Minute Medicine
-
Antidepressant fluvoxamine reduces long COVID fatigue in clinical trial - News-Medical
-
One Drug Wins and Another Fails for Long COVID Fatigue - MedPage Today
-
Common antidepressant can treat long COVID fatigue symptoms: study - CP24
-
Antidepressant Cuts Long COVID Fatigue. Metformin Not So Much. - ScienceBlog.com
-
Commonly Prescribed Antidepressant Shows Promise for Easing Long COVID Fatigue in New Clinical Trial | Newswise - Newswise
-
Drug-induced severe sideroblastic anemia following combined olanzapine and fluvoxamine therapy: a case report - Frontiers
-
Antidepressant fluvoxamine can save COVID-19 patients, McMaster-led research shows - McMaster News
-
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 - NEJM
-
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications - Nature
-
Researchers Think an Antidepressant Could Treat COVID-19 - The Mighty. Making health about people.
-
Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study - Psychiatry Online
-
US researchers evaluate antidepressant fluvoxamine for Covid-19 - Clinical Trials Arena
-
Coronavirus: Covid-19 Updates: Judge Denies N.Y.C. Police Union Bid to Block Vaccine Mandate (Published 2021) - The New York Times
-
Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine - Psychiatrist.com
-
Fluvoxamine may prevent serious illness in COVID-19 patients - WashU Medicine
-
Mechanisms of action of fluvoxamine for COVID-19: a historical review - Nature
-
An old drug saves lives of COVID-19 patients - McMaster News
-
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 - Frontiers
-
Common antidepressant slashes risk of COVID death, study says - Nature
-
Fluvoxamine Fails to Shorten COVID-19 Symptom Duration in Mild to Moderate Outpatients - The American Journal of Managed Care
-
Are antidepressants making Americans violent? - The Spectator
-
SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids | Translational Psychiatry - Nature
-
Antidepressant prevents most serious COVID-19 complications - futurity.org
-
Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization - Nature
-
Fluvoxamine: What Prescribers and Pharmacists Need to Know - Ontario COVID-19 Science Advisory Table
-
Fluvoxamine Attenuated Endoplasmic Reticulum Stress-Induced Leptin Resistance - Frontiers
-
Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor - Nature
-
Antidepressant Fluvoxamine May Reduce Severity of COVID-19 - respiratory-therapy.com
-
Fluvoxamine May Prevent Clinical Deterioration in Mild COVID-19 - Contagion Live
-
Trial supports use of fluvoxamine in patients with mild COVID-19 - European Pharmaceutical Review
-
Quetiapine co‐administration with fluvoxamine and duloxetine - Wiley Online Library
-
Antidepressant Fluvoxamine Offers No Symptom Relief for COVID-19 - respiratory-therapy.com
-
How a cheap antidepressant emerged as a promising Covid-19 treatment - Vox
-
High-dose fluvoxamine did not shorten COVID recovery times - cidrap.umn.edu
-
Another old drug is being tried vs. COVID-19, and might actually help - Inquirer.com
-
CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine - Frontiers
-
Trial finds that fluvoxamine doesn't speed COVID recovery - cidrap.umn.edu
-
The antidepressant fluvoxamine could keep mild COVID-19 from worsening - Science News
-
Why an antidepressant could be used to treat COVID-19 - gavi.org
-
Why the FDA rejected fluvoxamine as a Covid-19 drug - Vox
-
Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms - Duke University School of Medicine
-
Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control Study - Psychiatrist.com
-
Are we turning the corner on Covid-19 treatments? - Vox
-
More Patients Take Anti-Depressant to Beat COVID Symptoms - NBC Los Angeles
-
Antidepressant fluvoxamine can keep COVID-19 patients out of the hospital - American Society for Biochemistry and Molecular Biology
-
Analysis Boosts Fluvoxamine for COVID, But What's the Evidence? - Medscape
-
Pharmacotherapy Options for COVID-19: Does Fluvoxamine Have a Place in Therapy? - Contagion Live
-
Low-Cost Antidepressant Fluvoxamine Saves Lives of COVID-19 Patients – “Powerful Weapon Against the Virus” - SciTechDaily
-
A Closer Look at the New Fluvoxamine Trial Data - the-scientist.com
-
Tolerability and safety of fluvoxamine and other antidepressants - Wiley Online Library
-
Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis - Nature
-
Trial: Metformin, ivermectin, fluvoxamine don't prevent severe COVID - cidrap.umn.edu
-
What we know about the effectiveness of the antidepressant fluvoxamine versus covid-19 - Science Media Centre España
-
Antidepressant Fluvoxamine May Prevent COVID-19 Infections From Worsening - SciTechDaily
-
OCD drug spotlighted as potential COVID-19 treatment - cidrap.umn.edu
-
Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants - Frontiers
-
Common Anti-Depressant Pill Shows Promise In Fighting COVID-19 - NBC Los Angeles
-
COVID-19: UVA Discovery Spurs Clinical Trial of Antidepressant to Fight Virus - UVA Today
-
Fluvoxamine: Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant - 60 Minutes - CBS News
-
Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence? - University of Cincinnati
-
Fluvoxamine Ameliorates the Damage to the Neuro-Behavioral Status of Rats Caused by the Administration of Valproic Acid by Preventing Cognitive Memory Deficits and Decreased Hippocampal Cellular Proliferation - Cureus
-
Fluvoxamine: Cheap, generic anti-depressant called Luvox may reduce severe Covid-19 disease, study finds - cnn.com
-
Antidepressant Fluvoxamine Significantly Reduces Covid-19 Hospitalization - wsj.com
-
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents - NEJM
-
Fluvoxamine may prevent severe COVID-19 onset, suggests trial - European Pharmaceutical Review
-
A cheap antidepressant is showing promise treating COVID-19 in high-risk adults - NPR
-
Antidepressant shows promise for treating COVID symptoms, now patients can take part in at-home trial. - kare11.com
-
Growing Evidence for Potential Use of Antidepressants for Long COVID - Psychiatrist.com
-
How a Medication for OCD Ended Up in a Covid-19 Trial - WIRED
-
Do Antidepressants Reduce Mortality in COVID-19? - Psychiatry Advisor
-
Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study | Molecular Psychiatry - Nature
-
Can Antidepressant Medication Fluvoxamine Prevent Severe Covid-19 From Coronavirus? - Forbes
-
Fluvoxamine for symptomatic outpatients with COVID-19 - CMAJ
-
Doctor Submits Fluvoxamine EUA Application to FDA - MedPage Today
-
Antidepressant may prevent severe COVID-19, follow-up study indicates - WashU Medicine
-
A Cheap Antidepressant Can Keep Covid-19 Patients Out of the Hospital, Large Trial Finds - Gizmodo
-
Congressional briefing: Potential of fluvoxamine to counter COVID-19 - Federation of American Scientists
-
Successful Combination Therapy of Trazodone and Fluvoxamine for Pica in Alzheimer's Disease: A Case Report - Frontiers
-
FDA declines request for fluvoxamine to be used as COVID-19 treatment - Healio
-
Higher-Dose Fluvoxamine Fails for COVID Outpatients - MedPage Today
-
New study sheds light on impact of fluvoxamine on COVID symptoms in certain cases - Medical Xpress
-
Sulpiride in Combination with Fluvoxamine Increases in vivo Dopamine Release Selectively in Rat Prefrontal Cortex - Nature
-
Doctors Should Stop Prescribing Fluvoxamine for COVID - The People's Pharmacy
-
Column: With fluvoxamine, doctors find an old drug that may actually work against COVID-19 - Los Angeles Times
-
Fluvoxamine prompts the antitumor immune effect via inhibiting the PD-L1 expression on mice-burdened colon tumor - Wiley Online Library
-
Metformin, Ivermectin, Fluvoxamine Do Not Prevent Severe COVID-19 - Physician's Weekly
-
Opinion | Is Fluvoxamine the Covid Drug We’ve Been Waiting For? - wsj.com
-
Washington University trial studies antidepressant Fluvoxamine as treatment for Long COVID symptoms - KMOV
-
Can Prozac treat COVID? Perhaps, but a related drug may be better - The Conversation
-
COVID-19 research points to repurposed drugs - 60 Minutes - CBS News
-
Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients | Neuropsychopharmacology - Nature
-
In Alzheimer's, Antidepressants May Be Potential Treatment, Study Finds - Alzheimer's News Today
-
Cheap antidepressant could help treat COVID-19, study finds - Global News
-
IDSA Guidelines on the Treatment and Management of Patients with COVID-19 - IDSA
-
Can antidepressants reduce the risk of dying from COVID? - study - The Jerusalem Post
-
Scientists seek COVID treatment answers in cheap, older drugs - American Society for Biochemistry and Molecular Biology
-
FDA Rejects Cheap Antidepressant to Treat Early COVID - MedPage Today
-
Scientists Seek Covid Treatment Answers in Cheap, Older Drugs - California Healthline
-
In-Depth: As doctors ration COVID treatments, some turn to fluvoxamine - 10News.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.